ACTIVE SESSION TAPE Medical Devices $171M Cap Quant: HOLD

Why Is MaxCyte, Inc. (MXCT) Stock Up Today?

Updated Nov 22, 2026 6:42 AM ET ยท Prev Close $1.28

Pro Workspace
Last Session Price
$1.37 +7.03%
+$0.09 vs $1.28 prior close
Intraday Range
$1.25 โ€“ $1.42
Open $1.29
Relative Volume
0.77x Avg
1,108,161 sh
52-Week Range
$0.64 โ€“ $1.80
Benchmark Alpha
+10.67% vs SPY
+12.70% vs QQQ
20-Session Trend -9.3%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

MaxCyte, Inc. Advancing 7.03% on 0.77x Relative Volume

MaxCyte, Inc. (MXCT) is advancing 7.03% (+$0.09) to $1.37 on 0.77x average session volume. Relative to benchmarks, MXCT is outperforming the S&P 500 by +10.67%. 14-day RSI stands at 55.3, keeping momentum in a bullish regime.

NEWS 70% Weight
MaxCyte, Inc. Q3 2026 Earnings Call Summary

Moby summary of MaxCyte, Inc.'s Q3 2026 earnings call

TECHNICAL 68% Weight
Moving Average Structure: Bullish Alignment

Price ($1.37) holds above both 20-day ($1.36) and 50-day ($1.25) moving averages.

Volume Confirmation
LOW VOLUME (0.77x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

MXCT outperforming the S&P 500 by +10.67%
MXCT Session
+7.03%
$1.37
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +10.67% Alpha vs QQQ: +12.70% Alpha vs XLV: +7.15%

Options Flow & Execution Desk

Recent MXCT Catalyst Headlines

Verified Wire
MaxCyte Q3 Earnings Call Highlights

MaxCyte Nasdaq Mxct reported 49 third-quarter revenue growth and raised its 2026 revenue outlook, while announcing an agreement to acquire cell therapy materials supplier Akron Bio for 151.8 million. The transaction, whi

Yahoo Finance ยท Nov 10, 2026

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$1.29
Short-term support band
Upper Bound
$1.45
Short-term resistance band
Key Inflection Level
$1.36 (20-day SMA support)

Monitor volume expansion above 1.5x RVOL around $1.36 (20-day SMA support) for directional breakout confirmation.

Technical Regime (MXCT)

BULLISH MA TREND
RSI (14)
55.3
Bullish
20-Day SMA
$1.36
Above 20d
50-Day SMA
$1.25
Above 50d
MACD Signal
Bearish
MACD -0.02
ADX (14)
22.7
Moderate trend
10d Momentum
+0.11
Positive 10-day momentum

Retail & Crowd Sentiment

Quiet
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

MaxCyte announced management will participate in three upcoming investor conferences.

About MaxCyte, Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The โ€ฆ

Sector
Healthcare
Market Cap
$171M
Employees
114

Get Instant MXCT Catalyst Alerts

Receive an email alert when MXCT triggers an unusual volume breakout, options sweep, or rating shift.

MXCT Session & Catalyst FAQ

Why is MXCT stock up today?

MaxCyte, Inc. (MXCT) is advancing 7.03% (+$0.09) to $1.37 on 0.77x average session volume. Relative to benchmarks, MXCT is outperforming the S&P 500 by +10.67%. 14-day RSI stands at 55.3, keeping momentum in a bullish regime.

Is MXCT stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.77x relative volume (low participation). Our multi-factor model currently rates MXCT as HOLD. Review full valuation, quality, and timing signals on the MXCT Buy or Sell Decision Brief โ†’

What is MXCT's intrinsic value and expected trading range?

At $1.37, MXCT's modeled 1-to-3 session range is $1.29 โ€“ $1.45, with a key inflection level at $1.36 (20-day SMA support). Compare current price against multi-year cash flow projections in the MXCT Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for MXCT?

RSI at 55.3 reflects constructive bullish momentum. MXCT trades at $1.37 relative to its 20-day SMA ($1.36) and 50-day SMA ($1.25), reflecting a bullish moving-average structure.

Tradestie Flagship Research & Market Hubs